Hikma Pharmaceuticals Plc (HIK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 188,000 | 205,000 | 270,000 | 426,000 | 323,000 |
| Marketable Securities | 25,000 | 24,000 | 22,000 | 24,000 | 24,000 |
| Inventories | 986,000 | 891,000 | 776,000 | 695,000 | 757,000 |
| Other current assets | 991,000 | 908,000 | 857,000 | 884,000 | 760,000 |
| TOTAL | $2,263,000 | $2,100,000 | $1,999,000 | $2,094,000 | $1,922,000 |
| Non-Current Assets | |||||
| PPE Net | 1,326,000 | 1,141,000 | 1,081,000 | 1,146,000 | 1,068,000 |
| Intangibles | 1,156,000 | 1,100,000 | 1,124,000 | 892,000 | 876,000 |
| Other Non-Current Assets | 388,000 | 339,000 | 267,000 | 240,000 | 269,000 |
| TOTAL | $2,870,000 | $2,580,000 | $2,472,000 | $2,278,000 | $2,213,000 |
| Total Assets | $5,133,000 | $4,680,000 | $4,471,000 | $4,372,000 | $4,135,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 642,000 | 150,000 | 139,000 | 112,000 | 158,000 |
| Accounts payable and accrued liabilities | 358,000 | 309,000 | 291,000 | 262,000 | 279,000 |
| Other current liabilities | 296,000 | 205,000 | 155,000 | 126,000 | 128,000 |
| TOTAL | $1,978,000 | $1,339,000 | $1,077,000 | $1,016,000 | $1,028,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 607,000 | 975,000 | 1,074,000 | 651,000 | 692,000 |
| Other Non-Current Liabilities | 122,000 | 66,000 | 79,000 | 126,000 | 151,000 |
| TOTAL | $834,000 | $1,132,000 | $1,246,000 | $889,000 | $959,000 |
| Total Liabilities | $2,812,000 | $2,471,000 | $2,323,000 | $1,905,000 | $1,987,000 |
| Shareholders' Equity | |||||
| Common Shares | 40,000 | 40,000 | 40,000 | 42,000 | 41,000 |
| Retained earnings | 2,362,000 | 2,158,000 | 2,092,000 | 2,189,000 | 1,892,000 |
| Other shareholders' equity | -374,000 | -282,000 | -281,000 | -60,000 | -80,000 |
| TOTAL | $2,310,000 | $2,198,000 | $2,135,000 | $2,453,000 | $2,135,000 |
| Total Liabilities And Equity | $5,122,000 | $4,669,000 | $4,458,000 | $4,358,000 | $4,122,000 |